What is MMS's health score?

MAXIMUS, INC. (MMS) has a TradeApes health score of 56 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MMS's estimated fair value?

Based on our 5-year discounted cash flow model, MAXIMUS, INC.'s estimated fair value is $78.28 per share, representing a 35.9% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MMS undervalued or overvalued?

Our model currently rates MMS as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

2 free score cards remaining

MAXIMUS, INC. (MMS)

Technology Undervalued high mixed

$57.6

Updated: 2026-07-15

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

55 Mixed

Relative Value

58 Mixed

Capital Allocation

45 Mixed

Risk Management

70 Healthy

Est. Fair Value $78.28

DCF Upside +35.9%

Sector Rank #2012 of 15019

Key Findings

+ Low P/E — below 12×, potential value relative to earnings

Unlock Full Report →

− Low FCF yield — below 1%, price implies exceptional future growth

Unlock Full Report →

Industry Related Stocks

Accenture plc (ACN) ACV Auctions Inc. (ACVA) Advantage Solutions Inc. (ADV) Akso Health Group (AHG) AKAMAI TECHNOLOGIES INC (AKAM) Alight, Inc. / Delaware (ALIT)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.